Drugs / Tetanus Toxoid Adsorbed Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01163747 | Sep 2010 → Dec 2011 | rheumatoid arthritis | Genentech, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tetanus Toxoid Adsorbed Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01163747 ↗ |
| Modality | Vaccine | “Tetanus Toxoid Adsorbed Vaccine” NCT01163747 ↗ |
| Route | Intramuscular | “Intramuscular injection” NCT01163747 ↗ |